CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-13 | Tan Kevin CFO & Treasurer | Option exercise · Restricted Stock Units 10b5-1 | −10,625 | 21,250 | ||
| 2026-02-04 | Howton David T Chief Operating Officer | Sale 10b5-1 | −18,894 | $6.44 | $122K | 97,859 |
| 2026-02-04 | Cumbo Alexander President and CEO | Sale 10b5-1 | −48,913 | $6.44 | $315K | 222,018 |
| 2026-02-04 | Ganot Ilan Director | Sale 10b5-1 | −7,205 | $6.44 | $46K | 25,271 |
| 2026-02-04 | Tan Kevin CFO & Treasurer | Sale 10b5-1 | −14,783 | $6.44 | $95K | 94,201 |
| 2026-02-04 | Brooks Gabriel Chief Medical Officer | Sale 10b5-1 | −12,616 | $6.44 | $81K | 84,092 |
| 2026-02-04 | Hanrahan Jessie Chief Regulatory Officer | Sale 10b5-1 | −12,348 | $6.44 | $80K | 70,327 |
| 2026-02-04 | Herzich Paul Chief Technology Officer | Sale 10b5-1 | −10,905 | $6.44 | $70K | 69,067 |
| 2026-02-02 | Tan Kevin CFO & Treasurer | Sale 10b5-1 | −26,837 | $6.44 | $173K | 108,984 |
| 2026-02-02 | Cumbo Alexander President and CEO | Sale 10b5-1 | −80,258 | $6.44 | $517K | 270,931 |
| 2026-02-02 | Hanrahan Jessie Chief Regulatory Officer | Sale 10b5-1 | −26,535 | $6.44 | $171K | 82,675 |
| 2026-02-02 | Brooks Gabriel Chief Medical Officer | Sale 10b5-1 | −28,335 | $6.44 | $182K | 96,708 |
| 2026-02-02 | Howton David T Chief Operating Officer | Sale 10b5-1 | −37,771 | $6.44 | $243K | 116,753 |
| 2026-02-02 | Herzich Paul Chief Technology Officer | Sale 10b5-1 | −26,250 | $6.44 | $169K | 79,972 |
| 2026-01-31 | Tan Kevin CFO & Treasurer | Option exercise 10b5-1 | +33,075 | 135,821 | ||
| 2026-01-31 | Tan Kevin CFO & Treasurer | Option exercise · Restricted Stock Units 10b5-1 | −33,075 | 99,225 | ||
| 2026-01-31 | Cumbo Alexander President and CEO | Option exercise 10b5-1 | +100,400 | 351,189 | ||
| 2026-01-31 | Cumbo Alexander President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −100,400 | 301,200 | ||
| 2026-01-31 | Hanrahan Jessie Chief Regulatory Officer | Option exercise 10b5-1 | +27,625 | 109,210 | ||
| 2026-01-31 | Hanrahan Jessie Chief Regulatory Officer | Option exercise · Restricted Stock Units 10b5-1 | −27,625 | 82,875 |
Page 3 of 12 · 223 trades